bupivacaine has been researched along with Colonic Diseases in 6 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Colonic Diseases: Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
Excerpt | Relevance | Reference |
---|---|---|
"The study measured postoperative pain scores and opioid requirements." | 1.46 | Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery. ( Adhikary, SD; Choi, CS; Hollenbeak, CS; Messaris, E; Puleo, FJ; Quintili, A; Stokes, AL, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keller, DS | 2 |
Stulberg, JJ | 1 |
Lawrence, JK | 1 |
Delaney, CP | 2 |
Tahilramani, RN | 1 |
Flores-Gonzalez, JR | 1 |
Ibarra, S | 1 |
Haas, EM | 1 |
Stokes, AL | 1 |
Adhikary, SD | 1 |
Quintili, A | 1 |
Puleo, FJ | 1 |
Choi, CS | 1 |
Hollenbeak, CS | 1 |
Messaris, E | 1 |
Stuhldreher, JM | 1 |
Adamina, M | 1 |
Konopacka, A | 1 |
Brady, K | 1 |
Errando, CL | 1 |
Peiró, C | 1 |
Schulze, S | 1 |
Sommer, P | 1 |
Bigler, D | 1 |
Honnens, M | 1 |
Shenkin, A | 1 |
Cruickshank, AM | 1 |
Bukhave, K | 1 |
Kehlet, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Bilateral Mid-Abdominal Transverse Abdominis Plane and Rectus Sheath Blocks Comparing The Use of Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy Procedures.[NCT05224089] | Phase 4 | 114 participants (Anticipated) | Interventional | 2022-04-27 | Recruiting | ||
TAP Blocks Performed With Bupivacaine Versus Liposomal Bupivacaine in Colorectal Surgery Patients: A Prospective, Cluster Randomized Trial[NCT03638635] | Phase 4 | 63 participants (Actual) | Interventional | 2018-05-14 | Terminated (stopped due to Lack of personnel available to complete study.) | ||
"Analgesic Efficacy of Combined Transversus Abdominis Plane Block and Posterior Rectus Sheath Block in Patients Undergoing Laparoscopic Appendectomy"[NCT06088082] | Phase 3 | 100 participants (Anticipated) | Interventional | 2023-10-01 | Active, not recruiting | ||
Increased Postoperative Opioid Use is a Risk Factor for an Ileus After Laparoscopic Colorectal Surgery---A Case Control Study[NCT05262569] | 596 participants (Actual) | Observational | 2022-04-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Amount of ondansetron patient required postoperatively during hospital stay, in milligrams (NCT03638635)
Timeframe: Time of transfer to post operative suite to time of discharge (usually up to 4 days after surgery).
Intervention | mg (Mean) |
---|---|
Standard Bupivacaine | 2.9 |
Bupivacaine Liposome | 5.6 |
Total postoperative hospital stay in days (NCT03638635)
Timeframe: Date of surgery to date of discharge (usually up to 4 days after surgery).
Intervention | days (Median) |
---|---|
Standard Bupivacaine | 3 |
Bupivacaine Liposome | 3.5 |
Recorded on a scale of 0 (No pain) to 10 (Worst possible pain) (NCT03638635)
Timeframe: Approximately every 6 hours through postoperative day 3 by 1 pm
Intervention | units on a scale (Median) |
---|---|
Standard Bupivacaine | 3 |
Bupivacaine Liposome | 3 |
Number of days from time of surgery until patient tolerates clear liquid diet (NCT03638635)
Timeframe: From time of surgery until first time patient tolerates clear liquids without nausea or vomiting. Assessed until date of discharge (usually up to 4 days after surgery).
Intervention | days (Median) |
---|---|
Standard Bupivacaine | 0 |
Bupivacaine Liposome | 0 |
Number of days from day of surgery until patient tolerates low fiber diet (NCT03638635)
Timeframe: From time of surgery until first time patient tolerates a low fiber diet without nausea or vomiting. Assessed until date of discharge (usually up to 4 days after surgery).
Intervention | days (Median) |
---|---|
Standard Bupivacaine | 1.5 |
Bupivacaine Liposome | 1 |
Number of days from day of surgery until patient mobilization (NCT03638635)
Timeframe: From time of surgery until time of first patient ambulation post op. Assessed until date of discharge (usually up to 4 days after surgery).
Intervention | days (Median) |
---|---|
Standard Bupivacaine | 1 |
Bupivacaine Liposome | 0.5 |
Number of days from time of surgery until return of bowel function (NCT03638635)
Timeframe: From time of surgery until first time patient passes gas or stool per rectum or into ostomy bag. Assessed until date of discharge (usually up to 4 days after surgery).
Intervention | days (Median) |
---|---|
Standard Bupivacaine | 2 |
Bupivacaine Liposome | 2 |
2 trials available for bupivacaine and Colonic Diseases
Article | Year |
---|---|
Pilot study of a novel pain management strategy: evaluating the impact on patient outcomes.
Topics: Analgesics, Opioid; Bupivacaine; Colonic Diseases; Colorectal Surgery; Elective Surgical Procedures; | 2016 |
Effect of combined prednisolone, epidural analgesia, and indomethacin on the systemic response after colonic surgery.
Topics: Acetaminophen; Activities of Daily Living; Aged; Analgesia, Epidural; Body Temperature; Bupivacaine; | 1992 |
4 other studies available for bupivacaine and Colonic Diseases
Article | Year |
---|---|
Process control to measure process improvement in colorectal surgery: modifications to an established enhanced recovery pathway.
Topics: Abdominal Muscles; Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anesthetics, Local; Bupivac | 2014 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery.
Topics: Abdominal Muscles; Administration, Intravenous; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; | 2017 |
Effect of local anesthetics on postoperative pain and opioid consumption in laparoscopic colorectal surgery.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Analysis of Variance; | 2012 |
Another explanation for bowel and bladder dysfunction after spinal bupivacaine.
Topics: Anesthesia, Spinal; Bupivacaine; Colonic Diseases; Humans; Supine Position; Urinary Bladder Diseases | 2002 |